Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Surgical excision is the best treatment for SCC.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

mTOR inhibitors may help treat lung fibrosis.

Biliary fibrosis is crucial in liver diseases and understanding it can help prevent and treat these conditions.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Baricitinib was effective in treating alopecia areata in two major trials.

Removing a tumor may resolve associated skin and hair symptoms.

Baricitinib helps treat severe hair loss in people over 65.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Baricitinib is the most effective treatment for alopecia areata.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Long-term high-dose fluconazole can cause reversible hair loss.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.